Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 236.50
+2.32 (0.99%)
Apr 6, 2026, 3:30 PM IST
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 25.07 billion as of April 6, 2026. Its market cap has increased by 104.33% in one year.
Market Cap
25.07B
Enterprise Value
23.95B
Revenue
8.68B
Ranking
n/a
PE Ratio
22.98
Stock Price
236.50
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 25.07B, an increase of 249,324.38%. That is a compound annual growth rate of 38.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 25.07B | 44.95% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 40.31B |
| Sun Pharma Advanced Research Company | 40.26B |
| RPG Life Sciences | 31.77B |
| Orchid Pharma | 26.57B |
| Solara Active Pharma Sciences | 22.93B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.11B |
| Beta Drugs | 14.00B |